Disorders of Lipid Metabolism and its Correction in Chronic Kidney Disease

Journal Title: Нирки - Year 2016, Vol 2, Issue 16

Abstract

Chronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipid-modifying drugs — statins, fibrates, nicotinic acid was proposed.

Authors and Affiliations

O. O. Melnyk

Keywords

Related Articles

24-hour blood pressure profile in children with chronic pyelonephritis and chronic kidney disease stages I–III

Background. Blood pressure (BP) monitoring is important for the management of patients with chronic kidney disease (CKD), both for the conventional cardiovascular risk reduction and long-term preservation of kidney funct...

Cystatin C and chronic kidney disease in children

Background. Determination of diagnostically significant values of serum concentration of cystatin C in combination with the estimated glomerular filtration rate (GFR) gives clinicians an advantage in clearly differentiat...

Examination of a patient with renal pathology and idiopathic fever

Determination of causes of idiopathic fever is a fairly complicated process that in medical practice requires knowledge of the diagnostic algorithms for determining disease etiology accompanied by fever. For a nephrologi...

Download PDF file
  • EP ID EP208383
  • DOI -
  • Views 125
  • Downloads 0

How To Cite

O. O. Melnyk (2016). Disorders of Lipid Metabolism and its Correction in Chronic Kidney Disease. Нирки, 2(16), 85-95. https://europub.co.uk/articles/-A-208383